Follow
Jakob Haldrup Jensen
Jakob Haldrup Jensen
PhD, Post. Doc, Oxford University
Verified email at biomed.au.dk
Title
Cited by
Cited by
Year
A truncated reverse transcriptase enhances prime editing by split AAV vectors
Z Gao, S Ravendran, NS Mikkelsen, J Haldrup, H Cai, X Ding, ...
Molecular Therapy 30 (9), 2942-2951, 2022
452022
pegIT-a web-based design tool for prime editing
MV Anderson, J Haldrup, EA Thomsen, JH Wolff, JG Mikkelsen
Nucleic Acids Research 49 (W1), W505-W509, 2021
332021
FRMD6 has tumor suppressor functions in prostate cancer
J Haldrup, SH Strand, C Cieza-Borrella, ME Jakobsson, M Riedel, ...
Oncogene 40 (4), 763-776, 2021
272021
In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun
M Riedel, MF Berthelsen, H Cai, J Haldrup, M Borre, SR Paludan, ...
Oncogene 40 (13), 2437-2447, 2021
242021
piggyPrime: High-efficacy prime editing in human cells using piggyBac-based DNA transposition
JH Wolff, J Haldrup, EA Thomsen, S Andersen, JG Mikkelsen
Frontiers in Genome Editing 3, 786893, 2021
132021
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer
MB Ipsen, EMG Sørensen, EA Thomsen, S Weiss, J Haldrup, A Dalby, ...
Oncogene 41 (37), 4271-4281, 2022
92022
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification
J Haldrup, S Andersen, ARLV Labial, JH Wolff, FP Frandsen, TW Skov, ...
Nucleic Acids Research 51 (18), 10059-10074, 2023
52023
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR
J Haldrup, S Andersen, JÂG Mikkelsen
Cas ribonucleoprotein complexes supporting base editing, prime editing and …, 2023
52023
Simple autofluorescence-restrictive sorting of eGFP+ RPE cells allows reliable assessment of targeted retinal gene therapy
S Alsing, AB Lindholm, J Haldrup, EG Jensen, JG Mikkelsen, L Aagaard, ...
Frontiers in Drug Delivery 2, 898568, 2022
42022
Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening
J Haldrup, S Weiss, L Schmidt, KD Sørensen
Scientific Reports 13 (1), 9043, 2023
32023
The system can't perform the operation now. Try again later.
Articles 1–10